MR lesion load and cognitive function in patients with relapsing- remitting multiple sclerosis

American Journal of Neuroradiology

Volumn 20, Issue 10, 1999, Pages 1951-1955

  Fulton, Jennifer C ^a   Grossman, Robert I ^a   Udupa, Jayaram ^a   Mannon, Lois J ^a   Grossman, Murray ^c   Wei, Luogang ^a   Polansky, Marcia ^b   Kolson, Dennis L ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LONG TERM MEMORY; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL DISABILITY;

ADULT; COGNITION DISORDERS; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROPSYCHOLOGICAL TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0032692509     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991;41:685-691
2. Peyser JM, Edward KR, Poser CM. Psychological profiles in patients with multiple sclerosis. A preliminary investigation. Arch Neurol 1980;37:437-440
3. Prosiegel M, Michael C. Neuropsychology and multiple sclerosis. Diagnostic and rehabilitative approaches. J Neurol Sci 1993
4. Comi G, Filippi M, Martinelli V, et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 1995;132:222-227
5. Foong J, Rozewicz L, Quaghebeur G, et al. Executive function in multiple sclerosis. The role of frontal lobe pathology. Brain 1997;120:15-26
6. Amato M, Ponziani P, Pracucci G, et al. Cognitive performance in patients with early-onset MS. A 4-year follow-up. Conference on Neurobehavioral Disorders in Multiple Sclerosis: Diagnosis Underlying Pathology, Natural History and Therapeutic Intervention. 1992, vol I. pp 15-16 (abstr)
7. Beatty WW, Paul RH, Wilbanks SL, Hames KA. Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI). Neurology 1995;45:718-723
8. Kurtzke JF. Rating neurologic impairment in multiple sclerosis. An expanded disability status scale (EDSS). Neurology 1983; 33:1444-1452
9. Koopmans RA, Li DK, Grochowski E, et al. Benign versus chronic progressive multiple sclerosis. Magnetic resonance imaging features. Ann Neurol 1989;25:74-81
10. van Walderveen MA, Barkhof F, Hommes OR, et al. Correlating MRI and clinical disease activity in multiple sclerosis. Relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 1995;45:1684-1690
11. Comi G, Martinelli V, Medaglini S, et al. Correlation between multimodal evoked potentials and magnetic resonance imaging in multiple sclerosis. J Neurol 1989;236:4-8
12. Miki Y, Grossman RI, Udupa JK, et al. Computer-assisted quantitation of enhancing lesions in multiple sclerosis. Correlation with clinical classification. AJNR Am J Neuroradiol 1997;18: 705-710
13. Rao SM, Leo GJ, Haughton VM, et al. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989
14. Swirsky-Sacchetti T, Mitchell D, Seward J, et al. Neuropsychological and structural brain lesions in multiple sclerosis. A regional analysis. Neurology 1992;42:1291-1295
15. Callanan MM, Logsdail SJ, Ron MA, Warrington EK. Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. A psychometric and MRI study. Brain 1989;112:361-374
16. Franklin GM, Heaton RK, Nelson LM, et al. Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis. Neurology 1988;38:1826-1829
17. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis. Guidelines for research protocols. Ann Neurol 1983;13:227-231
18. Grossman M, Armstrong C, Onishi K, et al. Patterns of cognitive impairment in relapsing-remitting and chronic progressive multiple sclerosis. Neuropsychiatry Neuropsychol Behav Neurol 1994;7:194-210
19. Gronwall D. Paced auditory serial-addition task. A measure of recovery from concussion. Percept Mot Skills 1977;44:367-373
20. Newcombe F. Missle Wounds of the Brain. London: Oxford University Press; 1969
21. Spreen O, Benton AL. Neurosensory Center Comprehensive Examination for Aphasia. Rev Ed Victoria: University of Victoria, Laboratory of Neuropsychology; 1977
22. Gauthier LD, Joanette Y. The Bells test. A quantitative and qualitative test for visual neglect. Int J Clin Neuropsychol 1989; 6:49-54
23. Smith A. Symbol Digit Modalities Test: Manual. Los Angeles: Western Psychological Services; 1982
24. Lezak M. Neuropsychological Assessment. Oxford: Oxford University Press; 1983
25. Money JA. Standardized road map test of direction sense. San Raphael: Academic Therapy Publications; 1976
26. Udupa JK, Odhener, D. Samarasekera, S. et al. 3DVIEWNIX. An open, transportable, multidimensional, multimodality, multiparametric imaging software system. SPIE Proc 1994;2164:58-73
27. Udupa J, Samarasekera S. Fuzzy connectedness and object definition. SPIE Proc 1996;58:246-261
28. Udupa J, Wei L, Samarasekera S, et al. Multiple sclerosis lesion quantification using fuzzy connectedness principles. IEEE Trans Med Imaging 1997;16:598-609
29. Miki Y, Grossman RI, Udupa JK, et al. Isolated U-fiber involvement in multiple sclerosis. Neurology (in press)
30. Heaton RK, Nelson, L.M., Thompson, D.S., el al. Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol 1985;53:103-110
31. Beatty WW, Goodkin DE, Menson N, Beatty PA. Cognitive disturbances in patients with relapsing-remitting multiple sclerosis. Arch Neurol 1989;46:1113-1119
32. Matthews PM, Pioro E, Narayanan S. et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 1996; 119:715-722
33. Arnold DL, Riess GT, Matthews PM, et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 1994;36:76-82
34. Narayanan S, Fu L, Pioro E, et al. Imaging of axonal damage in multiple sclerosis. Spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997;41:385-391
35. van Buchem MA, Grossman RI, Armstrong C. et al. Correlation of volumetric magnetization transfer imaging with clinical data in multiple sclerosis, (in press)
36. Barkhof F, Mc Gowan J, van Waesberghe J, Grossman R. Hypointense MS lesions on T1-weighted spin echo MR images: their contribution in understanding MS evolution. J Neurol Neurosurg Psychiatry 1998;64:S77-S79
37. Haughton VM, Yetkin FZ, Rao SM, et al. Quantitative MR in the diagnosis of multiple sclerosis. Magn Reson Med 1992;26: 71-78
38. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-482
39. Haughton VM, Yetkin FZ, Rao SM, et al. Quantitative MR in the diagnosis of multiple sclerosis. Magn Reson Med 1992;26: 71-78
40. Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal appearing white matter on conventional MR images in patients with multiple sclerosis. Assessment with magnetization-transfer measurements. Radiology 1995;196:511-515
41. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis. Lesion characterization with magnetization transfer imaging. Radiology 1992;182: 483-489
42. Filippi M, Rocca MA, Martino G, Horsfield MA. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in multiple sclerosis. Ann Neurol 1998;43:809-814